nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—HTR1A—stomach cancer	0.733	1	CbGaD
Frovatriptan—Hypersensitivity—Fluorouracil—stomach cancer	0.000225	0.000995	CcSEcCtD
Frovatriptan—Dry mouth—Docetaxel—stomach cancer	0.000224	0.000995	CcSEcCtD
Frovatriptan—Haemoglobin—Methotrexate—stomach cancer	0.000224	0.000994	CcSEcCtD
Frovatriptan—Haemorrhage—Methotrexate—stomach cancer	0.000223	0.000989	CcSEcCtD
Frovatriptan—Pollakiuria—Doxorubicin—stomach cancer	0.000223	0.000989	CcSEcCtD
Frovatriptan—Myalgia—Capecitabine—stomach cancer	0.000222	0.000985	CcSEcCtD
Frovatriptan—Chest pain—Capecitabine—stomach cancer	0.000222	0.000985	CcSEcCtD
Frovatriptan—Arthralgia—Capecitabine—stomach cancer	0.000222	0.000985	CcSEcCtD
Frovatriptan—Confusional state—Docetaxel—stomach cancer	0.000222	0.000983	CcSEcCtD
Frovatriptan—Pharyngitis—Methotrexate—stomach cancer	0.000221	0.000982	CcSEcCtD
Frovatriptan—Anxiety—Capecitabine—stomach cancer	0.000221	0.000981	CcSEcCtD
Frovatriptan—Urinary tract disorder—Methotrexate—stomach cancer	0.00022	0.000977	CcSEcCtD
Frovatriptan—Anaphylactic shock—Docetaxel—stomach cancer	0.00022	0.000975	CcSEcCtD
Frovatriptan—Discomfort—Capecitabine—stomach cancer	0.00022	0.000973	CcSEcCtD
Frovatriptan—Epistaxis—Epirubicin—stomach cancer	0.000219	0.000973	CcSEcCtD
Frovatriptan—Urethral disorder—Methotrexate—stomach cancer	0.000219	0.00097	CcSEcCtD
Frovatriptan—Sinusitis—Epirubicin—stomach cancer	0.000218	0.000968	CcSEcCtD
Frovatriptan—Diarrhoea—Irinotecan—stomach cancer	0.000218	0.000965	CcSEcCtD
Frovatriptan—Dry mouth—Capecitabine—stomach cancer	0.000217	0.000963	CcSEcCtD
Frovatriptan—Shock—Docetaxel—stomach cancer	0.000216	0.000959	CcSEcCtD
Frovatriptan—Pruritus—Fluorouracil—stomach cancer	0.000216	0.000956	CcSEcCtD
Frovatriptan—Visual impairment—Methotrexate—stomach cancer	0.000215	0.000953	CcSEcCtD
Frovatriptan—Confusional state—Capecitabine—stomach cancer	0.000215	0.000952	CcSEcCtD
Frovatriptan—Tachycardia—Docetaxel—stomach cancer	0.000215	0.000952	CcSEcCtD
Frovatriptan—Bradycardia—Epirubicin—stomach cancer	0.000213	0.000942	CcSEcCtD
Frovatriptan—Dizziness—Irinotecan—stomach cancer	0.00021	0.000933	CcSEcCtD
Frovatriptan—Haemoglobin—Epirubicin—stomach cancer	0.00021	0.000931	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—stomach cancer	0.00021	0.00093	CcSEcCtD
Frovatriptan—Anorexia—Docetaxel—stomach cancer	0.00021	0.00093	CcSEcCtD
Frovatriptan—Shock—Capecitabine—stomach cancer	0.00021	0.000929	CcSEcCtD
Frovatriptan—Rhinitis—Epirubicin—stomach cancer	0.000209	0.000928	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—stomach cancer	0.000209	0.000928	CcSEcCtD
Frovatriptan—Haemorrhage—Epirubicin—stomach cancer	0.000209	0.000926	CcSEcCtD
Frovatriptan—Diarrhoea—Fluorouracil—stomach cancer	0.000209	0.000924	CcSEcCtD
Frovatriptan—Tinnitus—Methotrexate—stomach cancer	0.000208	0.000922	CcSEcCtD
Frovatriptan—Tachycardia—Capecitabine—stomach cancer	0.000208	0.000921	CcSEcCtD
Frovatriptan—Hypoaesthesia—Epirubicin—stomach cancer	0.000208	0.000921	CcSEcCtD
Frovatriptan—Pharyngitis—Epirubicin—stomach cancer	0.000207	0.000919	CcSEcCtD
Frovatriptan—Urinary tract disorder—Epirubicin—stomach cancer	0.000206	0.000914	CcSEcCtD
Frovatriptan—Hyperhidrosis—Capecitabine—stomach cancer	0.000206	0.000913	CcSEcCtD
Frovatriptan—Urethral disorder—Epirubicin—stomach cancer	0.000205	0.000908	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—stomach cancer	0.000203	0.0009	CcSEcCtD
Frovatriptan—Anorexia—Capecitabine—stomach cancer	0.000203	0.0009	CcSEcCtD
Frovatriptan—Vomiting—Irinotecan—stomach cancer	0.000202	0.000897	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—stomach cancer	0.000202	0.000895	CcSEcCtD
Frovatriptan—Dizziness—Fluorouracil—stomach cancer	0.000202	0.000893	CcSEcCtD
Frovatriptan—Visual impairment—Epirubicin—stomach cancer	0.000201	0.000892	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.0002	0.000888	CcSEcCtD
Frovatriptan—Chills—Methotrexate—stomach cancer	0.0002	0.000888	CcSEcCtD
Frovatriptan—Headache—Irinotecan—stomach cancer	0.000199	0.000884	CcSEcCtD
Frovatriptan—Insomnia—Docetaxel—stomach cancer	0.000199	0.000882	CcSEcCtD
Frovatriptan—Paraesthesia—Docetaxel—stomach cancer	0.000198	0.000876	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—stomach cancer	0.000197	0.000872	CcSEcCtD
Frovatriptan—Dyspnoea—Docetaxel—stomach cancer	0.000196	0.000869	CcSEcCtD
Frovatriptan—Somnolence—Docetaxel—stomach cancer	0.000196	0.000867	CcSEcCtD
Frovatriptan—Mental disorder—Methotrexate—stomach cancer	0.000196	0.000867	CcSEcCtD
Frovatriptan—Tinnitus—Epirubicin—stomach cancer	0.000195	0.000863	CcSEcCtD
Frovatriptan—Malnutrition—Methotrexate—stomach cancer	0.000194	0.000861	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—stomach cancer	0.000194	0.000861	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000194	0.00086	CcSEcCtD
Frovatriptan—Flushing—Epirubicin—stomach cancer	0.000194	0.000859	CcSEcCtD
Frovatriptan—Vomiting—Fluorouracil—stomach cancer	0.000194	0.000859	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—stomach cancer	0.000194	0.000859	CcSEcCtD
Frovatriptan—Dyspepsia—Docetaxel—stomach cancer	0.000194	0.000858	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—stomach cancer	0.000193	0.000857	CcSEcCtD
Frovatriptan—Insomnia—Capecitabine—stomach cancer	0.000193	0.000854	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—stomach cancer	0.000192	0.000852	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—stomach cancer	0.000192	0.00085	CcSEcCtD
Frovatriptan—Paraesthesia—Capecitabine—stomach cancer	0.000191	0.000848	CcSEcCtD
Frovatriptan—Decreased appetite—Docetaxel—stomach cancer	0.000191	0.000848	CcSEcCtD
Frovatriptan—Headache—Fluorouracil—stomach cancer	0.000191	0.000846	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—stomach cancer	0.000191	0.000846	CcSEcCtD
Frovatriptan—Dysgeusia—Methotrexate—stomach cancer	0.00019	0.000843	CcSEcCtD
Frovatriptan—Dyspnoea—Capecitabine—stomach cancer	0.00019	0.000842	CcSEcCtD
Frovatriptan—Fatigue—Docetaxel—stomach cancer	0.00019	0.000841	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—stomach cancer	0.000189	0.00084	CcSEcCtD
Frovatriptan—Nausea—Irinotecan—stomach cancer	0.000189	0.000838	CcSEcCtD
Frovatriptan—Pain—Docetaxel—stomach cancer	0.000188	0.000834	CcSEcCtD
Frovatriptan—Constipation—Docetaxel—stomach cancer	0.000188	0.000834	CcSEcCtD
Frovatriptan—Back pain—Methotrexate—stomach cancer	0.000188	0.000833	CcSEcCtD
Frovatriptan—Dyspepsia—Capecitabine—stomach cancer	0.000187	0.000831	CcSEcCtD
Frovatriptan—Chills—Epirubicin—stomach cancer	0.000187	0.000831	CcSEcCtD
Frovatriptan—Arrhythmia—Epirubicin—stomach cancer	0.000187	0.000827	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—stomach cancer	0.000186	0.000826	CcSEcCtD
Frovatriptan—Decreased appetite—Capecitabine—stomach cancer	0.000185	0.000821	CcSEcCtD
Frovatriptan—Fatigue—Capecitabine—stomach cancer	0.000184	0.000814	CcSEcCtD
Frovatriptan—Mental disorder—Epirubicin—stomach cancer	0.000183	0.000811	CcSEcCtD
Frovatriptan—Constipation—Capecitabine—stomach cancer	0.000182	0.000807	CcSEcCtD
Frovatriptan—Pain—Capecitabine—stomach cancer	0.000182	0.000807	CcSEcCtD
Frovatriptan—Malnutrition—Epirubicin—stomach cancer	0.000182	0.000806	CcSEcCtD
Frovatriptan—Feeling abnormal—Docetaxel—stomach cancer	0.000181	0.000804	CcSEcCtD
Frovatriptan—Nausea—Fluorouracil—stomach cancer	0.000181	0.000803	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methotrexate—stomach cancer	0.00018	0.000799	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—stomach cancer	0.00018	0.000799	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Docetaxel—stomach cancer	0.00018	0.000797	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—stomach cancer	0.000179	0.000795	CcSEcCtD
Frovatriptan—Flatulence—Epirubicin—stomach cancer	0.000179	0.000794	CcSEcCtD
Frovatriptan—Tension—Epirubicin—stomach cancer	0.000178	0.000791	CcSEcCtD
Frovatriptan—Dysgeusia—Epirubicin—stomach cancer	0.000178	0.000789	CcSEcCtD
Frovatriptan—Nervousness—Epirubicin—stomach cancer	0.000177	0.000783	CcSEcCtD
Frovatriptan—Back pain—Epirubicin—stomach cancer	0.000176	0.00078	CcSEcCtD
Frovatriptan—Feeling abnormal—Capecitabine—stomach cancer	0.000176	0.000778	CcSEcCtD
Frovatriptan—Malaise—Methotrexate—stomach cancer	0.000175	0.000777	CcSEcCtD
Frovatriptan—Muscle spasms—Epirubicin—stomach cancer	0.000175	0.000775	CcSEcCtD
Frovatriptan—Vertigo—Methotrexate—stomach cancer	0.000175	0.000774	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Capecitabine—stomach cancer	0.000174	0.000772	CcSEcCtD
Frovatriptan—Abdominal pain—Docetaxel—stomach cancer	0.000174	0.000771	CcSEcCtD
Frovatriptan—Body temperature increased—Docetaxel—stomach cancer	0.000174	0.000771	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—stomach cancer	0.000173	0.000769	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—stomach cancer	0.000173	0.000765	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—stomach cancer	0.000169	0.00075	CcSEcCtD
Frovatriptan—Ill-defined disorder—Epirubicin—stomach cancer	0.000169	0.000748	CcSEcCtD
Frovatriptan—Abdominal pain—Capecitabine—stomach cancer	0.000168	0.000746	CcSEcCtD
Frovatriptan—Body temperature increased—Capecitabine—stomach cancer	0.000168	0.000746	CcSEcCtD
Frovatriptan—Convulsion—Methotrexate—stomach cancer	0.000168	0.000746	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—stomach cancer	0.000168	0.000746	CcSEcCtD
Frovatriptan—Agitation—Epirubicin—stomach cancer	0.000167	0.000741	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—stomach cancer	0.000166	0.000735	CcSEcCtD
Frovatriptan—Chest pain—Methotrexate—stomach cancer	0.000165	0.000733	CcSEcCtD
Frovatriptan—Myalgia—Methotrexate—stomach cancer	0.000165	0.000733	CcSEcCtD
Frovatriptan—Arthralgia—Methotrexate—stomach cancer	0.000165	0.000733	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—stomach cancer	0.000165	0.000732	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—stomach cancer	0.000165	0.00073	CcSEcCtD
Frovatriptan—Malaise—Epirubicin—stomach cancer	0.000164	0.000727	CcSEcCtD
Frovatriptan—Discomfort—Methotrexate—stomach cancer	0.000163	0.000724	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—stomach cancer	0.000163	0.000724	CcSEcCtD
Frovatriptan—Vertigo—Epirubicin—stomach cancer	0.000163	0.000724	CcSEcCtD
Frovatriptan—Syncope—Epirubicin—stomach cancer	0.000163	0.000723	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—stomach cancer	0.000163	0.000721	CcSEcCtD
Frovatriptan—Hypersensitivity—Docetaxel—stomach cancer	0.000162	0.000718	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—stomach cancer	0.000162	0.000717	CcSEcCtD
Frovatriptan—Palpitations—Epirubicin—stomach cancer	0.000161	0.000712	CcSEcCtD
Frovatriptan—Confusional state—Methotrexate—stomach cancer	0.00016	0.000709	CcSEcCtD
Frovatriptan—Loss of consciousness—Epirubicin—stomach cancer	0.00016	0.000708	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methotrexate—stomach cancer	0.000159	0.000703	CcSEcCtD
Frovatriptan—Asthenia—Docetaxel—stomach cancer	0.000158	0.0007	CcSEcCtD
Frovatriptan—Convulsion—Epirubicin—stomach cancer	0.000158	0.000698	CcSEcCtD
Frovatriptan—Hypersensitivity—Capecitabine—stomach cancer	0.000157	0.000696	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—stomach cancer	0.000156	0.000692	CcSEcCtD
Frovatriptan—Pruritus—Docetaxel—stomach cancer	0.000156	0.00069	CcSEcCtD
Frovatriptan—Arthralgia—Epirubicin—stomach cancer	0.000155	0.000686	CcSEcCtD
Frovatriptan—Chest pain—Epirubicin—stomach cancer	0.000155	0.000686	CcSEcCtD
Frovatriptan—Myalgia—Epirubicin—stomach cancer	0.000155	0.000686	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—stomach cancer	0.000155	0.000685	CcSEcCtD
Frovatriptan—Anxiety—Epirubicin—stomach cancer	0.000154	0.000684	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methotrexate—stomach cancer	0.000153	0.000679	CcSEcCtD
Frovatriptan—Discomfort—Epirubicin—stomach cancer	0.000153	0.000678	CcSEcCtD
Frovatriptan—Asthenia—Capecitabine—stomach cancer	0.000153	0.000677	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—stomach cancer	0.000152	0.000672	CcSEcCtD
Frovatriptan—Dry mouth—Epirubicin—stomach cancer	0.000151	0.000671	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—stomach cancer	0.000151	0.00067	CcSEcCtD
Frovatriptan—Anorexia—Methotrexate—stomach cancer	0.000151	0.00067	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—stomach cancer	0.000151	0.000669	CcSEcCtD
Frovatriptan—Pruritus—Capecitabine—stomach cancer	0.000151	0.000668	CcSEcCtD
Frovatriptan—Diarrhoea—Docetaxel—stomach cancer	0.000151	0.000667	CcSEcCtD
Frovatriptan—Confusional state—Epirubicin—stomach cancer	0.00015	0.000663	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—stomach cancer	0.000149	0.000659	CcSEcCtD
Frovatriptan—Anaphylactic shock—Epirubicin—stomach cancer	0.000148	0.000658	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—stomach cancer	0.000148	0.000655	CcSEcCtD
Frovatriptan—Shock—Epirubicin—stomach cancer	0.000146	0.000647	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—stomach cancer	0.000146	0.000646	CcSEcCtD
Frovatriptan—Diarrhoea—Capecitabine—stomach cancer	0.000146	0.000646	CcSEcCtD
Frovatriptan—Dizziness—Docetaxel—stomach cancer	0.000145	0.000645	CcSEcCtD
Frovatriptan—Tachycardia—Epirubicin—stomach cancer	0.000145	0.000642	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000144	0.00064	CcSEcCtD
Frovatriptan—Hyperhidrosis—Epirubicin—stomach cancer	0.000143	0.000636	CcSEcCtD
Frovatriptan—Insomnia—Methotrexate—stomach cancer	0.000143	0.000636	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—stomach cancer	0.000143	0.000635	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—stomach cancer	0.000143	0.000635	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—stomach cancer	0.000143	0.000635	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—stomach cancer	0.000143	0.000633	CcSEcCtD
Frovatriptan—Paraesthesia—Methotrexate—stomach cancer	0.000142	0.000631	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—stomach cancer	0.000141	0.000627	CcSEcCtD
Frovatriptan—Anorexia—Epirubicin—stomach cancer	0.000141	0.000627	CcSEcCtD
Frovatriptan—Dyspnoea—Methotrexate—stomach cancer	0.000141	0.000627	CcSEcCtD
Frovatriptan—Somnolence—Methotrexate—stomach cancer	0.000141	0.000625	CcSEcCtD
Frovatriptan—Dizziness—Capecitabine—stomach cancer	0.000141	0.000624	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—stomach cancer	0.00014	0.000621	CcSEcCtD
Frovatriptan—Vomiting—Docetaxel—stomach cancer	0.00014	0.00062	CcSEcCtD
Frovatriptan—Dyspepsia—Methotrexate—stomach cancer	0.00014	0.000619	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—stomach cancer	0.000138	0.000614	CcSEcCtD
Frovatriptan—Decreased appetite—Methotrexate—stomach cancer	0.000138	0.000611	CcSEcCtD
Frovatriptan—Headache—Docetaxel—stomach cancer	0.000138	0.000611	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—stomach cancer	0.000137	0.000609	CcSEcCtD
Frovatriptan—Fatigue—Methotrexate—stomach cancer	0.000137	0.000606	CcSEcCtD
Frovatriptan—Pain—Methotrexate—stomach cancer	0.000136	0.000601	CcSEcCtD
Frovatriptan—Vomiting—Capecitabine—stomach cancer	0.000135	0.0006	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000135	0.000599	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—stomach cancer	0.000135	0.000599	CcSEcCtD
Frovatriptan—Insomnia—Epirubicin—stomach cancer	0.000134	0.000595	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—stomach cancer	0.000134	0.000594	CcSEcCtD
Frovatriptan—Headache—Capecitabine—stomach cancer	0.000133	0.000591	CcSEcCtD
Frovatriptan—Paraesthesia—Epirubicin—stomach cancer	0.000133	0.000591	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—stomach cancer	0.000133	0.000588	CcSEcCtD
Frovatriptan—Dyspnoea—Epirubicin—stomach cancer	0.000132	0.000586	CcSEcCtD
Frovatriptan—Somnolence—Epirubicin—stomach cancer	0.000132	0.000585	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—stomach cancer	0.000131	0.00058	CcSEcCtD
Frovatriptan—Nausea—Docetaxel—stomach cancer	0.000131	0.000579	CcSEcCtD
Frovatriptan—Feeling abnormal—Methotrexate—stomach cancer	0.000131	0.000579	CcSEcCtD
Frovatriptan—Dyspepsia—Epirubicin—stomach cancer	0.000131	0.000579	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methotrexate—stomach cancer	0.00013	0.000575	CcSEcCtD
Frovatriptan—Decreased appetite—Epirubicin—stomach cancer	0.000129	0.000572	CcSEcCtD
Frovatriptan—Fatigue—Epirubicin—stomach cancer	0.000128	0.000567	CcSEcCtD
Frovatriptan—Pain—Epirubicin—stomach cancer	0.000127	0.000562	CcSEcCtD
Frovatriptan—Constipation—Epirubicin—stomach cancer	0.000127	0.000562	CcSEcCtD
Frovatriptan—Nausea—Capecitabine—stomach cancer	0.000127	0.000561	CcSEcCtD
Frovatriptan—Abdominal pain—Methotrexate—stomach cancer	0.000125	0.000556	CcSEcCtD
Frovatriptan—Body temperature increased—Methotrexate—stomach cancer	0.000125	0.000556	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000125	0.000554	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—stomach cancer	0.000124	0.00055	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—stomach cancer	0.000123	0.000546	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—stomach cancer	0.000122	0.000543	CcSEcCtD
Frovatriptan—Feeling abnormal—Epirubicin—stomach cancer	0.000122	0.000542	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—stomach cancer	0.000122	0.000541	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Epirubicin—stomach cancer	0.000121	0.000538	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—stomach cancer	0.000121	0.000536	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—stomach cancer	0.000119	0.000529	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—stomach cancer	0.000118	0.000525	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—stomach cancer	0.000117	0.00052	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—stomach cancer	0.000117	0.00052	CcSEcCtD
Frovatriptan—Abdominal pain—Epirubicin—stomach cancer	0.000117	0.00052	CcSEcCtD
Frovatriptan—Body temperature increased—Epirubicin—stomach cancer	0.000117	0.00052	CcSEcCtD
Frovatriptan—Hypersensitivity—Methotrexate—stomach cancer	0.000117	0.000518	CcSEcCtD
Frovatriptan—Asthenia—Methotrexate—stomach cancer	0.000114	0.000504	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—stomach cancer	0.000113	0.000502	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000112	0.000498	CcSEcCtD
Frovatriptan—Pruritus—Methotrexate—stomach cancer	0.000112	0.000497	CcSEcCtD
Frovatriptan—Hypersensitivity—Epirubicin—stomach cancer	0.000109	0.000485	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—stomach cancer	0.000109	0.000481	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—stomach cancer	0.000109	0.000481	CcSEcCtD
Frovatriptan—Diarrhoea—Methotrexate—stomach cancer	0.000108	0.000481	CcSEcCtD
Frovatriptan—Asthenia—Epirubicin—stomach cancer	0.000106	0.000472	CcSEcCtD
Frovatriptan—Pruritus—Epirubicin—stomach cancer	0.000105	0.000465	CcSEcCtD
Frovatriptan—Dizziness—Methotrexate—stomach cancer	0.000105	0.000465	CcSEcCtD
Frovatriptan—Diarrhoea—Epirubicin—stomach cancer	0.000102	0.00045	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—stomach cancer	0.000101	0.000448	CcSEcCtD
Frovatriptan—Vomiting—Methotrexate—stomach cancer	0.000101	0.000447	CcSEcCtD
Frovatriptan—Headache—Methotrexate—stomach cancer	9.93e-05	0.00044	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—stomach cancer	9.85e-05	0.000437	CcSEcCtD
Frovatriptan—Dizziness—Epirubicin—stomach cancer	9.81e-05	0.000435	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—stomach cancer	9.71e-05	0.000431	CcSEcCtD
Frovatriptan—Vomiting—Epirubicin—stomach cancer	9.43e-05	0.000418	CcSEcCtD
Frovatriptan—Nausea—Methotrexate—stomach cancer	9.42e-05	0.000417	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—stomach cancer	9.39e-05	0.000416	CcSEcCtD
Frovatriptan—Headache—Epirubicin—stomach cancer	9.3e-05	0.000412	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—stomach cancer	9.08e-05	0.000402	CcSEcCtD
Frovatriptan—Nausea—Epirubicin—stomach cancer	8.81e-05	0.000391	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—stomach cancer	8.73e-05	0.000387	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—stomach cancer	8.6e-05	0.000381	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—stomach cancer	8.15e-05	0.000361	CcSEcCtD
Frovatriptan—HTR1A—Signaling Pathways—RNF43—stomach cancer	3.11e-05	0.000746	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RBP4—stomach cancer	3.1e-05	0.000742	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	3.1e-05	0.000742	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CXCL8—stomach cancer	3.1e-05	0.000742	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADRB1—stomach cancer	3.09e-05	0.000741	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—stomach cancer	3.04e-05	0.000728	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SUCLG1—stomach cancer	3.03e-05	0.000725	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—IDH3B—stomach cancer	3.03e-05	0.000725	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NDUFV1—stomach cancer	2.81e-05	0.000674	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NDUFS1—stomach cancer	2.81e-05	0.000674	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FST—stomach cancer	2.78e-05	0.000665	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—ADRB2—stomach cancer	2.76e-05	0.000661	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	2.75e-05	0.000659	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HSPB1—stomach cancer	2.72e-05	0.000652	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AGTR2—stomach cancer	2.72e-05	0.000652	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HBEGF—stomach cancer	2.72e-05	0.000651	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—F2R—stomach cancer	2.69e-05	0.000645	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—BMP2—stomach cancer	2.69e-05	0.000645	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RGS2—stomach cancer	2.68e-05	0.000642	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GAST—stomach cancer	2.68e-05	0.000642	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AGTR2—stomach cancer	2.66e-05	0.000638	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HSPB1—stomach cancer	2.66e-05	0.000638	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKR1C3—stomach cancer	2.65e-05	0.000634	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—F2R—stomach cancer	2.63e-05	0.000631	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—BMP2—stomach cancer	2.63e-05	0.000631	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR1A—stomach cancer	2.62e-05	0.000628	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKR1C3—stomach cancer	2.59e-05	0.000621	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR1A—stomach cancer	2.57e-05	0.000615	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGG—stomach cancer	2.54e-05	0.000608	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PRKCB—stomach cancer	2.54e-05	0.000608	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ANXA1—stomach cancer	2.53e-05	0.000606	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PGLS—stomach cancer	2.51e-05	0.000601	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—BLVRB—stomach cancer	2.51e-05	0.000601	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADRB2—stomach cancer	2.51e-05	0.000601	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PRKCB—stomach cancer	2.48e-05	0.000595	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ANXA1—stomach cancer	2.48e-05	0.000594	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PPP2R1A—stomach cancer	2.46e-05	0.000589	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRB1—stomach cancer	2.45e-05	0.000587	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKAA1—stomach cancer	2.44e-05	0.000586	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRB1—stomach cancer	2.4e-05	0.000575	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPAP2A—stomach cancer	2.39e-05	0.000573	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RBP4—stomach cancer	2.36e-05	0.000566	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CXCL8—stomach cancer	2.36e-05	0.000565	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RPS6—stomach cancer	2.34e-05	0.000561	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PRKCB—stomach cancer	2.3e-05	0.000552	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.3e-05	0.000551	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6ST—stomach cancer	2.29e-05	0.00055	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RPS6—stomach cancer	2.29e-05	0.000549	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PRKCB—stomach cancer	2.26e-05	0.00054	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6ST—stomach cancer	2.25e-05	0.000538	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HBEGF—stomach cancer	2.15e-05	0.000515	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CA1—stomach cancer	2.13e-05	0.000511	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—FBP1—stomach cancer	2.13e-05	0.000511	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NDUFA2—stomach cancer	2.13e-05	0.000511	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CKB—stomach cancer	2.13e-05	0.000511	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HBEGF—stomach cancer	2.11e-05	0.000505	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6R—stomach cancer	2.05e-05	0.00049	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—RHOA—stomach cancer	2.04e-05	0.000488	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HSPB1—stomach cancer	2.03e-05	0.000486	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGTR2—stomach cancer	2.03e-05	0.000486	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—BMP2—stomach cancer	2.01e-05	0.000481	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—F2R—stomach cancer	2.01e-05	0.000481	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLIN2—stomach cancer	2.01e-05	0.00048	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6R—stomach cancer	2e-05	0.00048	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—RHOA—stomach cancer	1.99e-05	0.000478	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRB2—stomach cancer	1.99e-05	0.000476	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKR1C3—stomach cancer	1.97e-05	0.000473	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CA2—stomach cancer	1.95e-05	0.000467	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PPP2R1A—stomach cancer	1.95e-05	0.000466	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRB2—stomach cancer	1.94e-05	0.000466	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PPP2R1A—stomach cancer	1.9e-05	0.000456	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NT5E—stomach cancer	1.9e-05	0.000455	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PGAM1—stomach cancer	1.9e-05	0.000455	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PRKCB—stomach cancer	1.89e-05	0.000453	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ANXA1—stomach cancer	1.89e-05	0.000452	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—RHOA—stomach cancer	1.85e-05	0.000443	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRB1—stomach cancer	1.83e-05	0.000438	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDH7A1—stomach cancer	1.81e-05	0.000434	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLCE1—stomach cancer	1.81e-05	0.000434	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—RHOA—stomach cancer	1.81e-05	0.000434	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SMAD4—stomach cancer	1.81e-05	0.000433	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CXCL8—stomach cancer	1.79e-05	0.000428	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SMAD4—stomach cancer	1.77e-05	0.000424	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCL8—stomach cancer	1.75e-05	0.000419	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RPS6—stomach cancer	1.75e-05	0.000418	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—UMPS—stomach cancer	1.74e-05	0.000417	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PRKCB—stomach cancer	1.72e-05	0.000412	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FYN—stomach cancer	1.72e-05	0.000411	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6ST—stomach cancer	1.71e-05	0.00041	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FYN—stomach cancer	1.68e-05	0.000402	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL8—stomach cancer	1.62e-05	0.000389	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PDHA1—stomach cancer	1.62e-05	0.000387	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ECHS1—stomach cancer	1.62e-05	0.000387	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGFR2—stomach cancer	1.61e-05	0.000386	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HBEGF—stomach cancer	1.6e-05	0.000384	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL8—stomach cancer	1.59e-05	0.000381	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGFR2—stomach cancer	1.58e-05	0.000378	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6R—stomach cancer	1.53e-05	0.000366	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TYMP—stomach cancer	1.52e-05	0.000364	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—FADS1—stomach cancer	1.52e-05	0.000364	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—RHOA—stomach cancer	1.52e-05	0.000364	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRB2—stomach cancer	1.48e-05	0.000355	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IRS2—stomach cancer	1.47e-05	0.000353	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PPP2R1A—stomach cancer	1.45e-05	0.000348	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IRS2—stomach cancer	1.44e-05	0.000346	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CAV1—stomach cancer	1.43e-05	0.000343	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOA1—stomach cancer	1.43e-05	0.000342	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SREBF2—stomach cancer	1.42e-05	0.000341	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—RORA—stomach cancer	1.41e-05	0.000337	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CAV1—stomach cancer	1.4e-05	0.000335	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOA1—stomach cancer	1.4e-05	0.000335	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—RHOA—stomach cancer	1.38e-05	0.00033	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRKCB—stomach cancer	1.36e-05	0.000326	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6ST—stomach cancer	1.36e-05	0.000325	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SMAD4—stomach cancer	1.35e-05	0.000323	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL8—stomach cancer	1.33e-05	0.000319	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRKCB—stomach cancer	1.33e-05	0.000319	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6ST—stomach cancer	1.33e-05	0.000318	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDOB—stomach cancer	1.32e-05	0.000316	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APC—stomach cancer	1.3e-05	0.000312	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FYN—stomach cancer	1.28e-05	0.000307	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APC—stomach cancer	1.28e-05	0.000306	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MAPK3—stomach cancer	1.25e-05	0.000299	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.24e-05	0.000298	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.24e-05	0.000297	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALOX5—stomach cancer	1.22e-05	0.000293	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MAPK3—stomach cancer	1.22e-05	0.000293	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL8—stomach cancer	1.21e-05	0.00029	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6R—stomach cancer	1.21e-05	0.00029	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DPYD—stomach cancer	1.21e-05	0.000289	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGFR2—stomach cancer	1.2e-05	0.000288	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MAPK1—stomach cancer	1.19e-05	0.000284	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EGFR—stomach cancer	1.19e-05	0.000284	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6R—stomach cancer	1.18e-05	0.000284	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MAPK1—stomach cancer	1.16e-05	0.000278	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EGFR—stomach cancer	1.16e-05	0.000278	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CA—stomach cancer	1.13e-05	0.000272	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SERPINE1—stomach cancer	1.13e-05	0.000271	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—KRAS—stomach cancer	1.12e-05	0.000269	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CA—stomach cancer	1.11e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SERPINE1—stomach cancer	1.11e-05	0.000266	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IRS2—stomach cancer	1.1e-05	0.000264	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—KRAS—stomach cancer	1.1e-05	0.000263	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.09e-05	0.000262	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RHOA—stomach cancer	1.09e-05	0.000262	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOS3—stomach cancer	1.08e-05	0.000259	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RHOA—stomach cancer	1.07e-05	0.000256	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CAV1—stomach cancer	1.07e-05	0.000255	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTT1—stomach cancer	1.07e-05	0.000255	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOA1—stomach cancer	1.06e-05	0.000255	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOS3—stomach cancer	1.06e-05	0.000254	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2A6—stomach cancer	1.05e-05	0.000252	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CA—stomach cancer	1.03e-05	0.000247	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKR1C3—stomach cancer	1.02e-05	0.000246	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCB—stomach cancer	1.01e-05	0.000243	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ERBB2—stomach cancer	1.01e-05	0.000242	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6ST—stomach cancer	1.01e-05	0.000242	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CA—stomach cancer	1.01e-05	0.000242	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ENO1—stomach cancer	9.98e-06	0.000239	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ERBB2—stomach cancer	9.9e-06	0.000237	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.82e-06	0.000235	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APC—stomach cancer	9.71e-06	0.000233	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL8—stomach cancer	9.59e-06	0.00023	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HRAS—stomach cancer	9.53e-06	0.000228	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL8—stomach cancer	9.39e-06	0.000225	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDKN1B—stomach cancer	9.36e-06	0.000224	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HRAS—stomach cancer	9.33e-06	0.000223	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	9.3e-06	0.000223	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDKN1B—stomach cancer	9.17e-06	0.00022	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—stomach cancer	9.12e-06	0.000218	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6R—stomach cancer	9.02e-06	0.000216	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCND1—stomach cancer	8.93e-06	0.000214	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—stomach cancer	8.93e-06	0.000214	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—JUN—stomach cancer	8.91e-06	0.000214	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CD44—stomach cancer	8.86e-06	0.000212	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	8.85e-06	0.000212	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EGFR—stomach cancer	8.85e-06	0.000212	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCND1—stomach cancer	8.75e-06	0.00021	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—JUN—stomach cancer	8.73e-06	0.000209	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—stomach cancer	8.67e-06	0.000208	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CDKN1A—stomach cancer	8.64e-06	0.000207	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.59e-06	0.000206	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—stomach cancer	8.49e-06	0.000203	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CDKN1A—stomach cancer	8.46e-06	0.000203	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	8.46e-06	0.000203	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	8.45e-06	0.000202	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK8—stomach cancer	8.43e-06	0.000202	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—KRAS—stomach cancer	8.36e-06	0.0002	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK8—stomach cancer	8.26e-06	0.000198	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RHOA—stomach cancer	8.15e-06	0.000195	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOS3—stomach cancer	8.06e-06	0.000193	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—stomach cancer	7.79e-06	0.000187	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—STAT3—stomach cancer	7.71e-06	0.000185	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	7.68e-06	0.000184	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—stomach cancer	7.63e-06	0.000183	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—STAT3—stomach cancer	7.55e-06	0.000181	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ERBB2—stomach cancer	7.54e-06	0.000181	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPP2R1A—stomach cancer	7.53e-06	0.00018	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTP1—stomach cancer	7.39e-06	0.000177	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK3—stomach cancer	7.37e-06	0.000177	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—stomach cancer	7.28e-06	0.000175	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK3—stomach cancer	7.21e-06	0.000173	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MYC—stomach cancer	7.17e-06	0.000172	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL8—stomach cancer	7.15e-06	0.000171	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HRAS—stomach cancer	7.11e-06	0.00017	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MYC—stomach cancer	7.02e-06	0.000168	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK1—stomach cancer	7.01e-06	0.000168	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EGFR—stomach cancer	7.01e-06	0.000168	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	6.98e-06	0.000167	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TYMS—stomach cancer	6.87e-06	0.000165	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK1—stomach cancer	6.86e-06	0.000164	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EGFR—stomach cancer	6.86e-06	0.000164	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—stomach cancer	6.8e-06	0.000163	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTM1—stomach cancer	6.79e-06	0.000163	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCND1—stomach cancer	6.66e-06	0.00016	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—JUN—stomach cancer	6.65e-06	0.000159	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KRAS—stomach cancer	6.62e-06	0.000159	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KRAS—stomach cancer	6.48e-06	0.000155	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—stomach cancer	6.47e-06	0.000155	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	6.45e-06	0.000154	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ERCC2—stomach cancer	6.38e-06	0.000153	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK8—stomach cancer	6.29e-06	0.000151	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	6.08e-06	0.000146	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—stomach cancer	6e-06	0.000144	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	5.96e-06	0.000143	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TP53—stomach cancer	5.88e-06	0.000141	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—stomach cancer	5.81e-06	0.000139	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TP53—stomach cancer	5.76e-06	0.000138	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STAT3—stomach cancer	5.75e-06	0.000138	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HRAS—stomach cancer	5.63e-06	0.000135	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAV1—stomach cancer	5.53e-06	0.000133	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA1—stomach cancer	5.52e-06	0.000132	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HRAS—stomach cancer	5.51e-06	0.000132	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK3—stomach cancer	5.49e-06	0.000132	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—stomach cancer	5.39e-06	0.000129	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MYC—stomach cancer	5.34e-06	0.000128	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.29e-06	0.000127	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—stomach cancer	5.27e-06	0.000126	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK1—stomach cancer	5.23e-06	0.000125	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EGFR—stomach cancer	5.23e-06	0.000125	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KRAS—stomach cancer	4.94e-06	0.000118	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—stomach cancer	4.86e-06	0.000117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	4.54e-06	0.000109	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TP53—stomach cancer	4.39e-06	0.000105	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—stomach cancer	4.37e-06	0.000105	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HRAS—stomach cancer	4.2e-06	0.000101	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NOS3—stomach cancer	4.18e-06	0.0001	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—stomach cancer	4.02e-06	9.63e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—stomach cancer	3.83e-06	9.17e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CA—stomach cancer	2.35e-06	5.64e-05	CbGpPWpGaD
